Mark your calendars as the Pune Pharma and Lab Expo gears up to unveil the latest innovations and advancements in the pharmaceutical and laboratory sectors from May 9th to 11th at the Hindustan Antibiotic Exhibition Ground, Pimpri. With over 150 exhibitors representing various segments including pharmaceuticals, packaging machinery, lab and analytical instruments, and allied industries, this event promises to be a melting pot of groundbreaking ideas and business opportunities, both domestically and internationally.
Organized by Exhivision Media, a prominent event management company, the expo stands as a cornerstone gathering in India’s thriving pharmaceutical and laboratory equipment market. With strategic investments in healthcare infrastructure and cutting-edge research and development, the 2024 edition of the Pune Pharma and Lab Expo aims to provide a dynamic platform for fostering B2B engagements, showcasing innovative products, and introducing the latest market trends tailored to professionals from the pharma, biotech, and healthcare sectors.
Recent market analyses project significant growth in the Laboratory Equipment Services Market, expected to reach $22.1 billion by 2027, with a notable CAGR of 11.1%. This surge is driven by increasing demand for precise diagnostics, reduced operational downtime, and cost-efficient solutions meeting stringent quality standards, particularly in the Asia-Pacific region.
Ajeetkumar Shukla, Director of Exhivision Media, expressed his excitement about bringing back the Pune Pharma and Lab Expo to Pune, hailing the city as a pivotal hub for pharmaceutical innovation and technology. Shukla emphasized that the event not only showcases industry breakthroughs but also serves as a vital platform for nurturing robust business connections across India and abroad.
The Expo will feature state-of-the-art exhibits in pharmaceutical machinery, lab and analytical instruments, and a diverse range of other products crucial to the pharmaceutical and healthcare sectors. With an expected turnout of over 5,000 attendees, including senior pharma executives, QA/QC managers, R&D professionals, and procurement managers from around the globe, the event aims to provide unparalleled access to the latest technologies and market dynamics.
In the fiscal year 2023, the Indian pharma market witnessed a notable year-on-year growth of nearly 5%, reaching a valuation of $49.78 billion. Particularly noteworthy was the modest 3% growth in exports, juxtaposed with a robust 7% surge in the domestic market. Developed markets exhibited an 8% growth trajectory, overcoming challenges posed by geopolitical conflicts and economic fluctuations in emerging economies.
